Promore – Reports and prospectus
| Lipopeptide AB - Årsredovisning 20140701–20150630 | Report (pdf) |
| Lipopeptide AB - Annual Report 20140701–20150630 | Report (pdf) |
BUSINESS MODEL
The RespiraSense™ business model consists of several components that together create a complete delivery that generates attractive gross margins and recurring revenues.
VISION
To avoid preventable respiratory failure events by transforming the standard of care in patient monitoring.
MISSION
To become the de facto standard-of-care for monitoring respiratory compromised patients in Europe and the US.